NO920624D0 - Reagens for paavisning av fibrinolytisk aktivitet - Google Patents

Reagens for paavisning av fibrinolytisk aktivitet

Info

Publication number
NO920624D0
NO920624D0 NO920624A NO920624A NO920624D0 NO 920624 D0 NO920624 D0 NO 920624D0 NO 920624 A NO920624 A NO 920624A NO 920624 A NO920624 A NO 920624A NO 920624 D0 NO920624 D0 NO 920624D0
Authority
NO
Norway
Prior art keywords
antibody
fibrinolytic enzyme
fibrinolytic
reagent
determination
Prior art date
Application number
NO920624A
Other languages
English (en)
Norwegian (no)
Other versions
NO920624L (no
Inventor
Johan Selmer
Niels Tromholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO920624L publication Critical patent/NO920624L/no
Publication of NO920624D0 publication Critical patent/NO920624D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO920624A 1989-08-18 1992-02-17 Reagens for paavisning av fibrinolytisk aktivitet NO920624D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
PCT/DK1990/000210 WO1991002546A1 (fr) 1989-08-18 1990-08-16 Reactif de detection d'activite fibrinolytique

Publications (2)

Publication Number Publication Date
NO920624L NO920624L (no) 1992-02-17
NO920624D0 true NO920624D0 (no) 1992-02-17

Family

ID=8129992

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920624A NO920624D0 (no) 1989-08-18 1992-02-17 Reagens for paavisning av fibrinolytisk aktivitet

Country Status (18)

Country Link
US (1) US5165912A (fr)
EP (1) EP0487594B1 (fr)
JP (1) JPH04507254A (fr)
KR (1) KR920703120A (fr)
AT (1) ATE92770T1 (fr)
AU (1) AU639940B2 (fr)
CA (1) CA2065147A1 (fr)
CZ (1) CZ280904B6 (fr)
DD (1) DD297064A5 (fr)
DE (1) DE69002769T2 (fr)
DK (2) DK408289D0 (fr)
ES (1) ES2058931T3 (fr)
FI (1) FI920669A0 (fr)
IE (1) IE65525B1 (fr)
IL (1) IL95407A (fr)
NO (1) NO920624D0 (fr)
NZ (1) NZ234937A (fr)
WO (1) WO1991002546A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
WO2009149199A2 (fr) * 2008-06-04 2009-12-10 Talecris Biotherapeutics, Inc. Composition, méthode et nécessaire pour la préparation de plasmine
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169232B1 (fr) * 1984-01-23 1990-04-25 For Energiteknikk Institutt Composition pour le marquage au technetium -99m de matières protéiques
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
CA1285223C (fr) * 1986-11-10 1991-06-25 New England Deaconess Hospital Detection des affections vasculaires

Also Published As

Publication number Publication date
US5165912A (en) 1992-11-24
KR920703120A (ko) 1992-12-17
CZ280904B6 (cs) 1996-05-15
IL95407A0 (en) 1991-06-30
FI920669A7 (fi) 1992-02-17
EP0487594B1 (fr) 1993-08-11
IL95407A (en) 1994-07-31
DD297064A5 (de) 1992-01-02
DK408289D0 (da) 1989-08-18
CA2065147A1 (fr) 1991-02-19
ATE92770T1 (de) 1993-08-15
NZ234937A (en) 1991-11-26
IE65525B1 (en) 1995-11-01
IE902977A1 (en) 1991-02-27
ES2058931T3 (es) 1994-11-01
DE69002769T2 (de) 1993-12-02
DE69002769D1 (de) 1993-09-16
WO1991002546A1 (fr) 1991-03-07
NO920624L (no) 1992-02-17
EP0487594A1 (fr) 1992-06-03
JPH04507254A (ja) 1992-12-17
AU639940B2 (en) 1993-08-12
DK0487594T3 (da) 1994-01-03
FI920669A0 (fi) 1992-02-17
AU6285990A (en) 1991-04-03
CZ404790A3 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
AU6264686A (en) Antibody complexes of hapten-modified diagnostic or therapeutic agents
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
ATE162403T1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
EP0259857A3 (en) Method of assaying physiologically active substances
FI103976B1 (fi) Menetelmä insuliinista riippuvan diabetes mellituksen (IDDM:n) diagnosoimiseksi in vitro ja siinä käyttökelpoinen välineistö ja polypeptidi
SE8000470L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
ATE260931T1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
SE7903821L (sv) Kinetisk metning av glykoskoncentrationen i kroppsvetskor och beredning herfor
NO920624D0 (no) Reagens for paavisning av fibrinolytisk aktivitet
NZ332641A (en) method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
DE3478958D1 (en) Protein conjugates of penicilloic acid, their preparation and use
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DK112290A (da) Vaevsplasminogenaktivator-variant
AU3039589A (en) Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor
DE69027441D1 (en) Ribozymenhemmer
GB2062226A (en) Reagent and method for the determination of human-muscle aldolase
JPS57148253A (en) Quantitative kit for cancer resisting agent
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
EP0241000A3 (fr) Procédé pour la détermination des compléments
RU98112436A (ru) Способ определения фибринолитической активности мочи
JPS57163319A (en) Preparation of antibody
NO177310C (no) Antigent polypeptid fra HBxAg, antistoff som reagerer med polypeptidet, diagnostisk analysesystem for bestemmelse av tilstedeværelsen av HBxAg i en kroppspröve, samt anvendelse av polypeptidet til in vitro diagnose
DK389584A (da) Fremgangsmaade til maerkning af fagocytceller